MedTrace Logo

Effects of Miricell Supplementation on Biomarkers of Healthy Aging and Autophagy

NCT07675200 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-06-30

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a dietary supplement called Miricell works to improve cellular health and signs of healthy aging in adults. It will also learn about the safety of Miricell.

The main questions it aims to answer are:

* Does Miricell improve markers of autophagy, which is the body's natural process for recycling damaged cells?
* Does Miricell support brain health, metabolic health, and visible signs of aging?
* What medical problems, if any, do participants experience while taking Miricell?

Researchers will compare Miricell to a placebo (a look-alike capsule that contains no active ingredients) to see if Miricell works better to support healthy aging.

Participants will:

* Take either one Miricell capsule or a placebo every day for 12 weeks with a morning meal.
* Visit the research clinic four times over the course of the study for checkups and tests.
* Complete memory and thinking tests, track their daily physical activity, and give blood samples to measure health changes.

Conditions

  • Autophagy
  • Healthy Aging

Interventions

DIETARY_SUPPLEMENT

Spermidine

Branded spermidine ingredient (Miricell® Rice Germ Extract) administered orally at a dose of 3.3 mg/day. Provided as a single opaque capsule to be ingested daily with water in the morning with a meal.

DIETARY_SUPPLEMENT

Placebo

Placebo capsule (microcrystalline cellulose) packaged in an identical-looking, opaque capsule to be ingested daily with water in the morning with a meal.

Sponsors & Collaborators

  • The Center for Applied Health Sciences, LLC

    collaborator INDUSTRY

  • Nutraland USA, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-09
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07675200 on ClinicalTrials.gov